These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2472734)

  • 1. Increased amount of serum type IV collagen peptide in human liver fibrosis as determined by enzyme-immunoassay with monoclonal antibodies.
    Matsumoto E; Muragaki Y; Ooshima A
    Acta Pathol Jpn; 1989 Apr; 39(4):217-23. PubMed ID: 2472734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration of serum laminin and type IV collagen in liver diseases assayed by a sandwich enzyme-immunoassay using monoclonal antibodies.
    Yokoya Y; Iwata K; Muragaki Y; Shiota C; Morimoto Y; Inoue M; Itoh H; Nishioka S; Ooshima A
    Clin Chim Acta; 1992 Sep; 210(1-2):109-18. PubMed ID: 1330375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies.
    Obata K; Iwata K; Ichida T; Inoue K; Matsumoto E; Muragaki Y; Ooshima A
    Clin Chim Acta; 1989 May; 181(3):293-303. PubMed ID: 2547537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen.
    Ueno T; Inuzuka S; Torimura T; Oohira H; Ko H; Obata K; Sata M; Yoshida H; Tanikawa K
    Scand J Gastroenterol; 1992 Jun; 27(6):513-20. PubMed ID: 1631498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease.
    Murawaki Y; Ikuta Y; Koda M; Yamada S; Kawasaki H
    J Hepatol; 1996 Feb; 24(2):148-54. PubMed ID: 8907567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of serum type IV collagen and the alteration of this collagen in various liver diseases].
    Wang JG
    Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):546-8. PubMed ID: 12536536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum immunoreactive collagen IV detected by monoclonal antibodies as a marker of severe fibrosis in patients with non-alcoholic fatty liver disease.
    Aida Y; Abe H; Tomita Y; Nagano T; Seki N; Sugita T; Itagaki M; Ishiguro H; Sutoh S; Aizawa Y
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):61-8. PubMed ID: 25822435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of serum procollagen III peptide and type IV collagen in patients with biliary atresia.
    Kobayashi H; Miyano T; Horikoshi K; Tokita A
    J Pediatr Surg; 1998 Jan; 33(1):112-4. PubMed ID: 9473113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme immunoassay of serum type IV collagen in anti-HCV positive chronic liver diseases.
    Matsuzaki Y; Yoshiga S; Sugitani T; Shoda J; Tanaka N; Osuga T
    Clin Chim Acta; 1993 Nov; 221(1-2):209-17. PubMed ID: 7512002
    [No Abstract]   [Full Text] [Related]  

  • 11. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum type IV collagen concentrations in diabetic patients with microangiopathy as determined by enzyme immunoassay with monoclonal antibodies.
    Matsumoto E; Matsumoto G; Ooshima A; Kikuoka H; Bessho H; Miyamura K; Nanjo K
    Diabetes; 1990 Aug; 39(8):885-90. PubMed ID: 1695588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum type IV collagen peptide in carbon tetrachloride-treated rats.
    Matsumoto E; Muragaki Y; Ooshima A
    Acta Pathol Jpn; 1989 Jan; 39(1):23-9. PubMed ID: 2711835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagen-binding activity of plasma vitronectin in chronic liver disease.
    Yamada S; Kobayashi J; Murawaki Y; Suou T; Kawasaki H
    Clin Chim Acta; 1996 Aug; 252(1):95-103. PubMed ID: 8814365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis].
    Wang T; Wang B; Liu X
    Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):185-90. PubMed ID: 11244978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
    Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
    J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of UDP-N-acetylglucosamine: beta-D-mannoside-1,4-N-acetylglucosaminyltransferase-III in patients sera with chronic hepatitis and liver cirrhosis using a monoclonal antibody.
    Song EY; Kim KS; Kim KA; Kim YD; Kwon DH; Byun SM; Kim HJ; Chung TW; Choe YK; Chung TW; Kim CH
    Glycoconj J; 2002 Jul; 19(6):415-21. PubMed ID: 14707488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
    El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
    Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.
    Murawaki Y; Ikuta Y; Koda M; Kawasaki H
    Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.